Member Info for sweepie3

I've been buying in the low 3s today, looking forward to where this transformed company goes to

.

Are we expecting any new news this week?

FVR should be valued at around $400m to $500m going by other companies values in that space, IF true then it might be worth £38.8m to £48.50m to Tern

How often do you get a global giant advertising a small companies product without that global giant not wanting to own the small company, has to make a FVR apotential target

100% agreed, will be in for more after the usual weakness is out of the way

Maybe late sells from today tomorrow then as really it should have held onto its early gains given the level of buying, as always I mistimed my re-entry but still have quite abit more to invest so if it continues downwards will add more. A completely different company compared with a few months ago

Guess a large sell to be announced at the end of the day?

Having read the RNS overnight I have become a believer again and bought back in

Looks like there will be some uplift in sales coming so have been glad to add at these prices

The vote will be passed but I would rather at this point that the company continued to slim down and everything disposed of except for the three main investments

Drug-GPT™ Named Finalist in PM360’s 2023 Trailblazer Awards

Aug 24, 2023

Drug-GPT™ Named Finalist in PM360’s 2023 Trailblazer Awards

We are thrilled to announce that Talking Medicines has been named a finalist in the prestigious PM360 Trailblazer Awards for our ground breaking initiative: Drug-GPT™. This innovative project represents a significant leap forward in the realm of healthcare marketing, harnessing the power of Artificial Intelligence (AI) and Large Language Models (LLMs) to provide unparalleled insights into patient and healthcare professional (HCP) sentiments.

Our initiative set out with a clear goal: to empower healthcare marketers with swift access to invaluable insights about patients and HCPs. Through the creation of the world’s first curated Patient Voice GPT, we’ve revolutionized the way healthcare advertising agencies tap into real-world experiences, opinions, and sentiments. Our focus was to bridge the gap between raw, unstructured data and meaningful, actionable intelligence.

Creating high-quality curated data through AI presented a complex challenge. We recognized the inherent risk in “garbage in, garbage out” when dealing with data of lesser quality. This is where our expertise shone. Talking Medicines harnessed AI, Machine Learning (ML), and Natural Language Processing (NLP) to sift through a vast array of unstructured sources—social media, online communities, message boards, and even closed “walled garden” platforms. Our innovative approach allowed us to transform these unstructured signals into structured intelligence.

Our journey culminated in the creation of Drug-GPT™, a purpose-built Healthcare LLM. This specialized GPT was meticulously designed to read only from curated data, ensuring that the insights it provided were rooted in accuracy and authenticity. A crucial aspect was classifying responses within the GPT, distinguishing between Patients and HCPs, and enabling insightful comparisons. This was a significant stride in making sure the AI-powered insights were tailored and relevant.

We are honored to be recognized as finalists in the PM360 Trailblazer Awards, an accolade that underscores our commitment to innovation, precision, and impactful execution. Our initiative’s ability to navigate the complexities of healthcare marketing, while delivering resonant messages with care and understanding, truly sets us apart. The intersection of curated data, AI, and LLMs has birthed Drug-GPT™, a powerful tool that opens new avenues in healthcare marketing. We extend our gratitude to the PM360 Editorial Advisory Board for recognizing our vision and to our dedicated team for their relentless pursuit of excellence.

As Anna Stashower, CEO and Publisher of PM360, aptly puts it, “These finalists accomplished all of that thanks to creative engagement methods, eye-catching images, immersive experiences, and more. But more importantly, they also showed an emphatic approach tha

BOSTON, MA – August 24, 2023 — PM360, a publication for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device industries, recently named FundamentalVR as a Trailblazer Company of the Year finalist for their Supplier/Vendor category.

FundamentalVR is a healthcare technology company with a mission to improve patient care by accelerating product and procedure rollout through their industry-leading virtual reality (VR) training platform Fundamental Surgery. Fundamental Surgery offers immersive HapticVR™ OR and clinical environments for HCPs and internal teams to physically interact with a virtual patient and digital twins of key equipment, medical devices, and surgical robotic systems. Partnering with medical device, pharmaceutical companies, and healthcare systems, FundamentalVR is helping to enhance skills acquisition and training globally.

“I am incredibly proud of our team and honored to be nominated as Company of the Year. With relentless focus on innovation, we will continue to empower our partners, enabling them to excel alongside us. Together, we strive to revolutionize surgical training and vital product and procedure adoption, ultimately elevating patient care and transforming the healthcare industry.”

Richard Vincent, CEO and Co-Founder of FundamentalVR

Since 2009, the PM360 Trailblazer Awards have recognized outstanding achievement and innovation in healthcare marketing. Each year, nominations are judged by the PM360 Editorial Advisory Board, a distinguished cross-section of industry experts.

The Company of the Year judging criteria included: Innovation (pursuit of excellence and innovation across the board in advertising, sales, product development, public relations, and communication); Talent Development (a record of attracting, developing, and keeping talent); and Social Responsibility (supporting patient access, civic and global involvement, and environmental consciousness). Companies of the Year are selected in five categories: Pharma/Biotech, Medical Device/Diagnostics, Specialty Pharma/Biotech, Advertising Agency, and Vendor/Supplier.

“In addition to working on some of our industry’s biggest brands, launching some of the most innovative offerings, and providing some of the most exiting forms of engagement this past year, each of our Company of the Year finalists are thriving in the facets that extend beyond the life sciences and marketing. These organizations are striving to achieve more diverse, productive, and fulfilled workforces, which result in company cultures worth emulating. Plus, their efforts to donate both funds and time to causes around their communities and for the betterment of our environment is exactly what we need to create a better world for us all.”

Conclusion: Leading the IoT Revolution with KeyScaler-as-a-Service

In a world where IoT innovation is reshaping industries, organizations must seize the opportunity to become leaders in this transformative landscape. The Forbes article provides a terrific roadmap for achieving IoT success, and we at Device Authority feel that our KSaaS solution perfectly complements these strategies. By considering this 10-point checklist and taking advantage of Device Authority’s expertise in helping companies successfully deploy IoT projects at scale, organizations can confidently embrace the IoT revolution and drive unparalleled business growth and innovation.

To learn more, review our IoT resources including the 9 Core Capabilities framework here: 9 Core Capabilities for Zero Trust in IoT

And, to learn how KSaaS can deliver a compelling ROI for your project, use our ROI calculator located here

8. IoT Lifecycle Management

Managing the full lifecycle of IoT infrastructure is critical for sustaining IoT ROI over the long term, and KSaaS excels in this aspect. Too often organizations mistake assigning a device’s initial credentials and provisioning those devices to their network as the complete process, but this is just the first step in the process. Device Authority has published several frameworks to help customers understand the complete IoT device lifecycle, including the Enterprise IoT Lifecycle Blueprint, and the 9 Core Capabilities for Zero Trust in IoT. These frameworks cover a device’s lifecycle from initial manufacturing, all the way to decommissioning and recommissioning, and include leveraging security capabilities like continuous assurance using SBOMs, external threat intelligence to inform device authorization, and more. These frameworks can help provide the details needed to support Fernandes’ call for continuous improvement and adaptability in the face of evolving technology landscapes.

9. Prioritizing Users in Ongoing Improvements

User experience is central to IoT success, and KSaaS prioritizes user-centric enhancements. The entire KeyScaler platform, including KeyScaler Central, KeyScaler Edge, and the soon to be released KeyScaler AI, has followed a user-driving development model incorporating customer feedback from real-world IoT use cases across multiple industries. Through this user feedback, our customers have helped tailor one of the industry’s leading IoT solutions that meets evolving needs and expectations in Automotive, Medical, Industrial, Public Sector and other markets. Our solution empowers organizations to actively engage with users, refining workflows and enhancing functionality based on real-world insights, just as Fernandes recommends.

10. Forging Strategic Partnerships

Collaboration is key in the IoT ecosystem, and the Device Authority KeyScaler platform, including KSaaS supports this approach. As described above, the flexible architecture and unique integration capabilities of KeyScaler, in particular KSaaS, enables organizations to seamlessly integrate with their existing technology providers. KSaaS includes prebuilt integrations with the leading PKI platform providers, IoT application providers, and cybersecurity vendors. This ecosystem approach aligns with Fernandes’ counsel to leverage partnerships for enhanced capabilities and a greater likelihood of success. Device Authority’s close partnerships with Microsoft, EnTrust, Venafi, Avnet and many others are all examples of seamless ecosystem integration enabling customers to solve complex security challenges for real use cases supporting their digital transformation.

3. Evaluating Infrastructure Needs

As organizations expand their IoT footprint, integrating with existing systems becomes paramount. KSaaS excels in this aspect, seamlessly integrating with legacy systems and modern platforms alike. This interoperability maximizes investments in existing systems, minimizes disruption, and optimizes the utilization of infrastructure resources, ensuring that the IoT solution aligns harmoniously with the existing technology landscape. We work hard to ensure our platform remains agnostic, which customers demand – any device, any platform, and any PKI platform or identity provider.

4. Learning from the Initial Deployment

The value of experiencing a real-world deployment cannot be overstated. KSaaS was specifically designed for its ease of deployment, empowering customers to conduct secure and controlled POC or pilot deployments quickly and easily, gathering valuable insights that inform an optimized production environment. By providing detailed audit logs, analytics, and device management capabilities, KSaaS ensures that lessons learned are effectively applied for a successful full-scale rollout.

5. Understanding Your Data

Data is the lifeblood of IoT initiatives, and KSaaS safeguards this valuable asset. As we often say, if you can’t trust the device, you can’t trust the data. Through KeyScaler’s comprehensive device identity lifecycle and end-to-end data encryption mechanisms, organizations can confidently utilize the data generated by IoT devices to make informed decisions. The solution’s ability to handle massive volumes of data while ensuring its confidentiality and integrity according to a Zero Trust strategy, aligns perfectly with Fernandes’ emphasis on deriving actionable insights from IoT-generated data.

6. Security as a Mindset

IoT security is paramount, and KSaaS makes it a core principle. By integrating seamlessly with cybersecurity protocols and aligning to all 5 pillars of the NIST Cybersecurity Framework, our solution provides end-to-end security, from device provisioning to data transmission. With identity-based access control, patented processes for leveraing PKI for IoT, and continuous monitoring and assurance leveraging a device’s SBOM, organizations can instill a security-first culture that embeds security throughout the entire solution lifecycle.

7. Designing for Scalability

Scalability is essential for future-proofing IoT initiatives, and KSaaS is designed with this in mind. Built on Azure using Microsoft’s Well Architected Framework, KSaaS’ flexible architecture and elastic scalability ensure that as the number of connected devices grows, the system continues to function seamlessly, turning scalability challenges into growth opportunities.

August 24, 2023

Device Authority KeyScaler as a Service: Mastering and Empowering Successful IoT Implementation Aligned With The CISA Framework To Deliver Zero Trust For IoT

The Internet of Things (IoT) has unlocked a realm of innovation and transformation, promising to revolutionize industries across the board. Author Felipe Fernandes successfully points out in his article for Forbes “Mastering IoT Implementation: Strategies For Successful Outcomes,” the success of IoT initiatives hinges on careful planning, strategic execution, and a commitment to addressing key challenges. The 10-point framework outlined in this article is a great checklist for any organization planning or actively implementing an IoT project. This document will explore how the Device Authority KeyScaler-as-a-Service (KSaaS) solution, recently recognized by Microsoft as the Rising Azure Technology Partner of the Year, provides a powerful cloud-based technology platform to enable this vision, and will offer additional insights for organizations to unlock the full potential of their IoT endeavors.

1. Crafting a Clear IoT Vision

Just as the article highlights, a well-defined vision is the cornerstone of any successful IoT project. For example, managing the fusion of AI and IoT is one of today’s most critical technological challenges the industry grapples with. Data originating from IoT devices is increasingly being used to train sophisticated AI models. How do you ensure the data can be trusted? It starts with device trust which typically aligns to an organization’s broader Zero Trust security strategy. Currently we see more customers adopting a cloud first approach, such as KSaaS, to accelerate their digital transformation journey and provide a secure foundation for their IoT vision without having to incur costly management and infrastructure overhead. Using industry-proven cloud service businesses can help enforce a zero-trust framework by clearly defining and enforcing security policies, establishing complete device and data trust at scale, and ensuring confidentiality and integrity of their data while aligning their IoT initiatives with their broader organizational goals.

2. Gaining Internal Buy-In

Collaboration across departments is pivotal for IoT success, and integration of both IT and OT security practices is critical to an organization’s success. KSaaS ensures a unified approach in solving many security use cases at scale from one software cloud platform service, enforcing centralized Zero Trust policy all the way to the Internet Edge. This approach not only offers advanced security to the “new” perimeter of identity but also empowers cross-functional teams by providing comprehensive and flexible access controls and identity-based authentication mechanisms, which fosters an environment of trust and accountability, where stakeholders from central IT to field-based security departments can clearly see the benefits of IoT.

How did you guess

According to this poster

PWhite7316 Aug '23 - 11:36 - 337821 of 337821

0 1 1

No. The surge in trading levels on 04/09/2023 was due solely to the Wyld/SpaceX news.

Do not confuse a MBO with a delisting.

A MBO can be triggered by the management acquiring 30% or more of the shares. They then have to offer shareholders the highest price over the last 12 months, no resolution is required for this process.

A delisting is when management think shareholders can best be served as a private concern. A resolution and majority vote of the shareholders is required for this.

Of course depends on the price but don't they need 75% of the shares, surely this at this price would be voted down

Some meaty buying this morning among the OMG what an awful update that is sellers but what you can't get away if that DA is and will be worth a huge amount of money, I still expect they will be sold by Xmas, next results will look very different